世界のハンセン病治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Leprosy Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z3400
• 出版社/出版日：QYResearch / 2021年4月
※2025年版があります。お問い合わせください。
• レポート形態：英文、PDF、91ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥565,500 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥848,250 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,131,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査資料では、ハンセン病治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（スルホン、フェナジン誘導体、抗管状薬、その他）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。
・市場概要
・ハンセン病治療の市場動向
・企業の競争状況、市場シェア
・ハンセン病治療の種類別市場規模（スルホン、フェナジン誘導体、抗管状薬、その他）
・ハンセン病治療の用途別市場規模（病院、クリニック、その他）
・ハンセン病治療の北米市場規模2016-2027（アメリカ、カナダ）
・ハンセン病治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等）
・ハンセン病治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・ハンセン病治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・ハンセン病治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Glaxo Smithcline、Systopic Laboratories、Cadila Pharmaceuticals、Acme Pharmaceuticals、Macleods Pharmaceuticals、Novartis、Astra Zeneca、Lark Laboratories）
・結論

Leprosy, also known as Hansen’s disease (HD), is a long-term infection by the bacterium Mycobacterium leprae or Mycobacterium lepromatosis. Initially, infections are without symptoms and typically remain this way for 5 to 20 years. Symptoms that develop include granulomas of the nerves, respiratory tract, skin, and eyes. This may result in a lack of ability to feel pain, which can lead to the loss of parts of extremities due to repeated injuries or infection due to unnoticed wounds. Weakness and poor eyesight may also be present.
The two main types of disease are based on the number of bacteria present: paucibacillary and multibacillary. The two types are differentiated by the number of poorly pigmented, numb skin patches present, with paucibacillary having five or fewer and multibacillary having more than five. The diagnosis is confirmed by finding acid-fast bacilli in a biopsy of the skin or by detecting the DNA using polymerase chain reaction.

Market Analysis and Insights: Global Leprosy Treatment Market
The global Leprosy Treatment market size is projected to reach US$ 2937 million by 2026, from US$ 2585.9 million in 2019, at a CAGR of 1.8% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Leprosy Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Leprosy Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Leprosy Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Leprosy Treatment market.

Global Leprosy Treatment Scope and Market Size
Leprosy Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Leprosy Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Sulfone
Phenazine Derivative
Anti-Tubercular Drugs
Others

Segment by Application
Hospitals
Clinics
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Glaxo Smithcline
Systopic Laboratories
Cadila Pharmaceuticals
Acme Pharmaceuticals
Macleods Pharmaceuticals
Novartis
Astra Zeneca
Lark Laboratories

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Leprosy Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Sulfone
1.2.3 Phenazine Derivative
1.2.4 Anti-Tubercular Drugs
1.2.5 Others
1.3 Market by Application
1.3.1 Global Leprosy Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Leprosy Treatment Market Perspective (2016-2027)
2.2 Leprosy Treatment Growth Trends by Regions
2.2.1 Leprosy Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Leprosy Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Leprosy Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Leprosy Treatment Industry Dynamic
2.3.1 Leprosy Treatment Market Trends
2.3.2 Leprosy Treatment Market Drivers
2.3.3 Leprosy Treatment Market Challenges
2.3.4 Leprosy Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Leprosy Treatment Players by Revenue
3.1.1 Global Top Leprosy Treatment Players by Revenue (2016-2021)
3.1.2 Global Leprosy Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Leprosy Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Leprosy Treatment Revenue
3.4 Global Leprosy Treatment Market Concentration Ratio
3.4.1 Global Leprosy Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Leprosy Treatment Revenue in 2020
3.5 Leprosy Treatment Key Players Head office and Area Served
3.6 Key Players Leprosy Treatment Product Solution and Service
3.7 Date of Enter into Leprosy Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Leprosy Treatment Breakdown Data by Type
4.1 Global Leprosy Treatment Historic Market Size by Type (2016-2021)
4.2 Global Leprosy Treatment Forecasted Market Size by Type (2022-2027)

5 Leprosy Treatment Breakdown Data by Application
5.1 Global Leprosy Treatment Historic Market Size by Application (2016-2021)
5.2 Global Leprosy Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Leprosy Treatment Market Size (2016-2027)
6.2 North America Leprosy Treatment Market Size by Type
6.2.1 North America Leprosy Treatment Market Size by Type (2016-2021)
6.2.2 North America Leprosy Treatment Market Size by Type (2022-2027)
6.2.3 North America Leprosy Treatment Market Size by Type (2016-2027)
6.3 North America Leprosy Treatment Market Size by Application
6.3.1 North America Leprosy Treatment Market Size by Application (2016-2021)
6.3.2 North America Leprosy Treatment Market Size by Application (2022-2027)
6.3.3 North America Leprosy Treatment Market Size by Application (2016-2027)
6.4 North America Leprosy Treatment Market Size by Country
6.4.1 North America Leprosy Treatment Market Size by Country (2016-2021)
6.4.2 North America Leprosy Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Leprosy Treatment Market Size (2016-2027)
7.2 Europe Leprosy Treatment Market Size by Type
7.2.1 Europe Leprosy Treatment Market Size by Type (2016-2021)
7.2.2 Europe Leprosy Treatment Market Size by Type (2022-2027)
7.2.3 Europe Leprosy Treatment Market Size by Type (2016-2027)
7.3 Europe Leprosy Treatment Market Size by Application
7.3.1 Europe Leprosy Treatment Market Size by Application (2016-2021)
7.3.2 Europe Leprosy Treatment Market Size by Application (2022-2027)
7.3.3 Europe Leprosy Treatment Market Size by Application (2016-2027)
7.4 Europe Leprosy Treatment Market Size by Country
7.4.1 Europe Leprosy Treatment Market Size by Country (2016-2021)
7.4.2 Europe Leprosy Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Leprosy Treatment Market Size (2016-2027)
8.2 Asia-Pacific Leprosy Treatment Market Size by Type
8.2.1 Asia-Pacific Leprosy Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Leprosy Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Leprosy Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Leprosy Treatment Market Size by Application
8.3.1 Asia-Pacific Leprosy Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Leprosy Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Leprosy Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Leprosy Treatment Market Size by Region
8.4.1 Asia-Pacific Leprosy Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Leprosy Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Leprosy Treatment Market Size (2016-2027)
9.2 Latin America Leprosy Treatment Market Size by Type
9.2.1 Latin America Leprosy Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Leprosy Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Leprosy Treatment Market Size by Type (2016-2027)
9.3 Latin America Leprosy Treatment Market Size by Application
9.3.1 Latin America Leprosy Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Leprosy Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Leprosy Treatment Market Size by Application (2016-2027)
9.4 Latin America Leprosy Treatment Market Size by Country
9.4.1 Latin America Leprosy Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Leprosy Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Leprosy Treatment Market Size (2016-2027)
10.2 Middle East & Africa Leprosy Treatment Market Size by Type
10.2.1 Middle East & Africa Leprosy Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Leprosy Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Leprosy Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Leprosy Treatment Market Size by Application
10.3.1 Middle East & Africa Leprosy Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Leprosy Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Leprosy Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Leprosy Treatment Market Size by Country
10.4.1 Middle East & Africa Leprosy Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Leprosy Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Glaxo Smithcline
11.1.1 Glaxo Smithcline Company Details
11.1.2 Glaxo Smithcline Business Overview
11.1.3 Glaxo Smithcline Leprosy Treatment Introduction
11.1.4 Glaxo Smithcline Revenue in Leprosy Treatment Business (2016-2021)
11.1.5 Glaxo Smithcline Recent Development
11.2 Systopic Laboratories
11.2.1 Systopic Laboratories Company Details
11.2.2 Systopic Laboratories Business Overview
11.2.3 Systopic Laboratories Leprosy Treatment Introduction
11.2.4 Systopic Laboratories Revenue in Leprosy Treatment Business (2016-2021)
11.2.5 Systopic Laboratories Recent Development
11.3 Cadila Pharmaceuticals
11.3.1 Cadila Pharmaceuticals Company Details
11.3.2 Cadila Pharmaceuticals Business Overview
11.3.3 Cadila Pharmaceuticals Leprosy Treatment Introduction
11.3.4 Cadila Pharmaceuticals Revenue in Leprosy Treatment Business (2016-2021)
11.3.5 Cadila Pharmaceuticals Recent Development
11.4 Acme Pharmaceuticals
11.4.1 Acme Pharmaceuticals Company Details
11.4.2 Acme Pharmaceuticals Business Overview
11.4.3 Acme Pharmaceuticals Leprosy Treatment Introduction
11.4.4 Acme Pharmaceuticals Revenue in Leprosy Treatment Business (2016-2021)
11.4.5 Acme Pharmaceuticals Recent Development
11.5 Macleods Pharmaceuticals
11.5.1 Macleods Pharmaceuticals Company Details
11.5.2 Macleods Pharmaceuticals Business Overview
11.5.3 Macleods Pharmaceuticals Leprosy Treatment Introduction
11.5.4 Macleods Pharmaceuticals Revenue in Leprosy Treatment Business (2016-2021)
11.5.5 Macleods Pharmaceuticals Recent Development
11.6 Novartis
11.6.1 Novartis Company Details
11.6.2 Novartis Business Overview
11.6.3 Novartis Leprosy Treatment Introduction
11.6.4 Novartis Revenue in Leprosy Treatment Business (2016-2021)
11.6.5 Novartis Recent Development
11.7 Astra Zeneca
11.7.1 Astra Zeneca Company Details
11.7.2 Astra Zeneca Business Overview
11.7.3 Astra Zeneca Leprosy Treatment Introduction
11.7.4 Astra Zeneca Revenue in Leprosy Treatment Business (2016-2021)
11.7.5 Astra Zeneca Recent Development
11.8 Lark Laboratories
11.8.1 Lark Laboratories Company Details
11.8.2 Lark Laboratories Business Overview
11.8.3 Lark Laboratories Leprosy Treatment Introduction
11.8.4 Lark Laboratories Revenue in Leprosy Treatment Business (2016-2021)
11.8.5 Lark Laboratories Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Leprosy Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Sulfone
Table 3. Key Players of Phenazine Derivative
Table 4. Key Players of Anti-Tubercular Drugs
Table 5. Key Players of Others
Table 6. Global Leprosy Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Leprosy Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Leprosy Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Leprosy Treatment Market Share by Regions (2016-2021)
Table 10. Global Leprosy Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Leprosy Treatment Market Share by Regions (2022-2027)
Table 12. Leprosy Treatment Market Trends
Table 13. Leprosy Treatment Market Drivers
Table 14. Leprosy Treatment Market Challenges
Table 15. Leprosy Treatment Market Restraints
Table 16. Global Leprosy Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Leprosy Treatment Market Share by Players (2016-2021)
Table 18. Global Top Leprosy Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Leprosy Treatment as of 2020)
Table 19. Ranking of Global Top Leprosy Treatment Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Leprosy Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Leprosy Treatment Product Solution and Service
Table 23. Date of Enter into Leprosy Treatment Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Leprosy Treatment Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Leprosy Treatment Revenue Market Share by Type (2016-2021)
Table 27. Global Leprosy Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Leprosy Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Leprosy Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Leprosy Treatment Revenue Market Share by Application (2016-2021)
Table 31. Global Leprosy Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Leprosy Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Leprosy Treatment Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Leprosy Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Leprosy Treatment Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Leprosy Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Leprosy Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Leprosy Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Leprosy Treatment Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Leprosy Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Leprosy Treatment Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Leprosy Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Leprosy Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Leprosy Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Leprosy Treatment Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Leprosy Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Leprosy Treatment Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Leprosy Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Leprosy Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Leprosy Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Leprosy Treatment Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Leprosy Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Leprosy Treatment Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Leprosy Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Leprosy Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Leprosy Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Leprosy Treatment Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Leprosy Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Leprosy Treatment Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Leprosy Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Leprosy Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Leprosy Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 63. Glaxo Smithcline Company Details
Table 64. Glaxo Smithcline Business Overview
Table 65. Glaxo Smithcline Leprosy Treatment Product
Table 66. Glaxo Smithcline Revenue in Leprosy Treatment Business (2016-2021) & (US$ Million)
Table 67. Glaxo Smithcline Recent Development
Table 68. Systopic Laboratories Company Details
Table 69. Systopic Laboratories Business Overview
Table 70. Systopic Laboratories Leprosy Treatment Product
Table 71. Systopic Laboratories Revenue in Leprosy Treatment Business (2016-2021) & (US$ Million)
Table 72. Systopic Laboratories Recent Development
Table 73. Cadila Pharmaceuticals Company Details
Table 74. Cadila Pharmaceuticals Business Overview
Table 75. Cadila Pharmaceuticals Leprosy Treatment Product
Table 76. Cadila Pharmaceuticals Revenue in Leprosy Treatment Business (2016-2021) & (US$ Million)
Table 77. Cadila Pharmaceuticals Recent Development
Table 78. Acme Pharmaceuticals Company Details
Table 79. Acme Pharmaceuticals Business Overview
Table 80. Acme Pharmaceuticals Leprosy Treatment Product
Table 81. Acme Pharmaceuticals Revenue in Leprosy Treatment Business (2016-2021) & (US$ Million)
Table 82. Acme Pharmaceuticals Recent Development
Table 83. Macleods Pharmaceuticals Company Details
Table 84. Macleods Pharmaceuticals Business Overview
Table 85. Macleods Pharmaceuticals Leprosy Treatment Product
Table 86. Macleods Pharmaceuticals Revenue in Leprosy Treatment Business (2016-2021) & (US$ Million)
Table 87. Macleods Pharmaceuticals Recent Development
Table 88. Novartis Company Details
Table 89. Novartis Business Overview
Table 90. Novartis Leprosy Treatment Product
Table 91. Novartis Revenue in Leprosy Treatment Business (2016-2021) & (US$ Million)
Table 92. Novartis Recent Development
Table 93. Astra Zeneca Company Details
Table 94. Astra Zeneca Business Overview
Table 95. Astra Zeneca Leprosy Treatment Product
Table 96. Astra Zeneca Revenue in Leprosy Treatment Business (2016-2021) & (US$ Million)
Table 97. Astra Zeneca Recent Development
Table 98. Lark Laboratories Company Details
Table 99. Lark Laboratories Business Overview
Table 100. Lark Laboratories Revenue in Leprosy Treatment Business (2016-2021) & (US$ Million)
Table 101. Lark Laboratories Recent Development
Table 102. Research Programs/Design for This Report
Table 103. Key Data Information from Secondary Sources
Table 104. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Leprosy Treatment Market Share by Type: 2020 VS 2027
Figure 2. Sulfone Features
Figure 3. Phenazine Derivative Features
Figure 4. Anti-Tubercular Drugs Features
Figure 5. Others Features
Figure 6. Global Leprosy Treatment Market Share by Application: 2020 VS 2027
Figure 7. Hospitals Case Studies
Figure 8. Clinics Case Studies
Figure 9. Others Case Studies
Figure 10. Leprosy Treatment Report Years Considered
Figure 11. Global Leprosy Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Leprosy Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Leprosy Treatment Market Share by Regions: 2020 VS 2027
Figure 14. Global Leprosy Treatment Market Share by Regions (2022-2027)
Figure 15. Global Leprosy Treatment Market Share by Players in 2020
Figure 16. Global Top Leprosy Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Leprosy Treatment as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Leprosy Treatment Revenue in 2020
Figure 18. Global Leprosy Treatment Revenue Market Share by Type (2016-2021)
Figure 19. Global Leprosy Treatment Revenue Market Share by Type (2022-2027)
Figure 20. North America Leprosy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Leprosy Treatment Market Share by Type (2016-2027)
Figure 22. North America Leprosy Treatment Market Share by Application (2016-2027)
Figure 23. North America Leprosy Treatment Market Share by Country (2016-2027)
Figure 24. United States Leprosy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Leprosy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Leprosy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Leprosy Treatment Market Share by Type (2016-2027)
Figure 28. Europe Leprosy Treatment Market Share by Application (2016-2027)
Figure 29. Europe Leprosy Treatment Market Share by Country (2016-2027)
Figure 30. Germany Leprosy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Leprosy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Leprosy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Leprosy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Leprosy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Leprosy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Leprosy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Leprosy Treatment Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Leprosy Treatment Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Leprosy Treatment Market Share by Region (2016-2027)
Figure 40. China Leprosy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Leprosy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Leprosy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Leprosy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Leprosy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Leprosy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Leprosy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Leprosy Treatment Market Share by Type (2016-2027)
Figure 48. Latin America Leprosy Treatment Market Share by Application (2016-2027)
Figure 49. Latin America Leprosy Treatment Market Share by Country (2016-2027)
Figure 50. Mexico Leprosy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Leprosy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Leprosy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Leprosy Treatment Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Leprosy Treatment Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Leprosy Treatment Market Share by Country (2016-2027)
Figure 56. Turkey Leprosy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Leprosy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Leprosy Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Glaxo Smithcline Revenue Growth Rate in Leprosy Treatment Business (2016-2021)
Figure 60. Systopic Laboratories Revenue Growth Rate in Leprosy Treatment Business (2016-2021)
Figure 61. Cadila Pharmaceuticals Revenue Growth Rate in Leprosy Treatment Business (2016-2021)
Figure 62. Acme Pharmaceuticals Revenue Growth Rate in Leprosy Treatment Business (2016-2021)
Figure 63. Macleods Pharmaceuticals Revenue Growth Rate in Leprosy Treatment Business (2016-2021)
Figure 64. Novartis Revenue Growth Rate in Leprosy Treatment Business (2016-2021)
Figure 65. Astra Zeneca Revenue Growth Rate in Leprosy Treatment Business (2016-2021)
Figure 66. Lark Laboratories Revenue Growth Rate in Leprosy Treatment Business (2016-2021)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed

以下、関連資料のご紹介

世界の脂質障害治療市場規模・現状・予測（2021年-2027年）

Global Lipid Disorder Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z3432 2021年4月 98Pages
QYResearch社発行の本調査資料では、脂質障害治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（アトルバスタチン、フルバスタチン、ロスバスタチン、シンバスタチン、プラバスタチン、その他）、用途別市場規模（病院、クリニック、その他）、主要...

世界のジフテリア治療市場規模・現状・予測（2021年-2027年）

Global Diphtheria Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z1902 2021年4月 95Pages
QYResearch社発行の本調査資料では、ジフテリア治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（破傷風免疫グロブリン、破傷風トキソイド、破傷風-ジフテリア、ジフテリアトキソイド、百日咳）、用途別市場規模（抗毒素、抗生物質、その他）、主...

世界の水疱性類天疱瘡治療市場規模・現状・予測（2021年-2027年）

Global Bullous Pemphigoid Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z1030 2021年4月 97Pages
QYResearch社発行の本調査資料では、水疱性類天疱瘡治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（免疫抑制薬、ステロイド、抗生物質・防腐剤、鎮痛薬）、用途別市場規模（病院薬局、小売薬局、通信販売薬局）、主要地域別市場規模（北米、アメ...

世界のナルコレプシー治療市場規模・現状・予測（2021年-2027年）

Global Narcolepsy Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z4022 2021年4月 94Pages
QYResearch社発行の本調査資料では、ナルコレプシー治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（オキシベートナトリウム、抗うつ薬、中枢神経刺激薬、その他）、用途別市場規模（脱力発作を伴う原発性ナルコレプシー、脱力発作を伴わない原発...

世界の多発性内分泌腺腫症治療市場規模・現状・予測（2021年-2027年）

Global Multiple Endocrine Neoplasia Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z3952 2021年4月 97Pages
QYResearch社発行の本調査資料では、多発性内分泌腺腫症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（薬物治療、外科治療）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中...

世界の軟骨肉腫治療市場規模・現状・予測（2021年-2027年）

Global Chondrosarcoma Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z1305 2021年4月 99Pages
QYResearch社発行の本調査資料では、軟骨肉腫治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（外科的治療、化学療法、放射線療法）、用途別市場規模（病院、専門クリニック、がん治療センター）、主要地域別市場規模（北米、アメリカ、ヨーロッパ...

世界の裂肛治療市場規模・現状・予測（2021年-2027年）

Global Anal Fissure Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z0309 2021年4月 91Pages
QYResearch社発行の本調査資料では、裂肛治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（局所ニトログリセリン、カルシウムチャネル遮断薬、便軟化剤、その他）、用途別市場規模（クリニック、病院、その他）、主要地域別市場規模（北米、アメリ...

世界の早産治療市場規模・現状・予測（2021年-2027年）

Global Premature Labor Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z4769 2021年4月 93Pages
QYResearch社発行の本調査資料では、早産治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（プロゲステロン、OBE-022、レトシバン、その他）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、ア...

世界の消化器疾患治療市場規模・現状・予測（2021年-2027年）

Global Digestive Distress Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z1859 2021年4月 92Pages
QYResearch社発行の本調査資料では、消化器疾患治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（上部消化管、下部消化管）、用途別市場規模（病院薬局、オンライン薬局、ドラッグストア、専門クリニック）、主要地域別市場規模（北米、アメリカ、...

世界の痙性治療市場規模・現状・予測（2021年-2027年）

Global Spasticity Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z5383 2021年4月 99Pages
QYResearch社発行の本調査資料では、痙性治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（理学療法、医学治療）、用途別市場規模（子供用、大人用）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南ア...

世界の肺がん治療薬市場規模・現状・予測（2021年-2027年） Lung Cancer Treatment Drugs are durgs used to cure lung cancer. In the coming years, it is expected that the global Lung Cancer Treatment Drugs market will advance with higher growth rate as compared to previous years. Factors such as Smoking, Rising cases of infections, Rising rates of fast growing…
世界の胃炎治療薬市場規模・現状・予測（2021年-2027年） Gastritis is inflammation of the lining of the stomach. It may occur as a short episode or may be of a long duration. There may be no symptoms but, when symptoms are present, the most common is upper abdominal pain. Other possible symptoms include nausea and vomiting, bloating, loss of appetite and …
世界の白血病治療薬市場規模・現状・予測（2021年-2027年） Leukemia Treatment Drugs is used to cure Leukemia. Increasing geriatric population base and high unmet needs regarding early diagnosis and treatment of leukemia are the key factors driving the leukemia therapeutics market. Market Analysis and Insights: Global Leukemia Treatment Drugs Market The glob…
世界の眼瞼炎治療薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Blepharitis Treatment Drugs Market The global Blepharitis Treatment Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity…
世界の眼瞼炎治療薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Blepharitis Treatment Drugs Market The global Blepharitis Treatment Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity…